Provided by Tiger Trade Technology Pte. Ltd.

Sonoma Pharmaceuticals, Inc.

1.34
0.0000
Post-market: 1.340.00000.00%18:27 EDT
Volume:66.58K
Turnover:89.27K
Market Cap:6.41M
PE:-1.10
High:1.36
Open:1.33
Low:1.32
Close:1.34
52wk High:5.18
52wk Low:0.8501
Shares:4.79M
Float Shares:4.77M
Volume Ratio:0.58
T/O Rate:1.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2200
EPS(LYR):-1.8854
ROE:-42.52%
ROA:-5.37%
PB:0.97
PE(LYR):-0.71

Loading ...

Sonoma Pharmaceuticals Special Shareholder Meeting Lacked Quorum, Chairman Canceled Session

Reuters
·
Aug 20

Sonoma Pharmaceuticals - Cancels Special Meeting Due to Lack of Quorum - SEC Filing

THOMSON REUTERS
·
Aug 20

Sonoma Pharmaceuticals Q1 Operating Expenses USD 2.6 Million

Reuters
·
Aug 06

Sonoma Pharmaceuticals Q1 Revenue Rises on US Growth

Reuters
·
Aug 06

Sonoma Pharmaceuticals Q1 Gross Profit USD 2.6 Million

THOMSON REUTERS
·
Aug 06

Sonoma Pharmaceuticals Q1 EPS $(0.09) Up From $(0.76) YoY, Sales $6.406M Up From $4.015M YoY

Benzinga Earnings
·
Aug 06

Sonoma Pharmaceuticals Turns EBITDA Positive for First Time with Record Quarterly Revenue

Benzinga Earnings
·
Aug 06

Sonoma Pharma FY27 Q1 Net Loss Narrows 73.41% to USD 330,000; Revenue Rises 60% to USD 6.41 Million

Reuters
·
Aug 06

Sonoma Pharmaceuticals Announces Annual Shareholder Meeting

Reuters
·
Jul 29

Sonoma Pharma Wins FDA 510(k) Clearance Expanding Microdacyn Wound Solution Indications

Reuters
·
Jun 30

Sonoma Pharma ups at-the-market stock offering to $3.64 million

Reuters
·
Jun 19

Sonoma Pharmaceuticals - Increases Maximum Aggregate Offering Price of Common Stock to $3.64 Mln - SEC Filing

THOMSON REUTERS
·
Jun 19

Sonoma Pharmaceuticals Q4 revenue rises 48% on US growth

Reuters
·
Jun 17

Sonoma Pharmaceuticals Q4 EPS $(0.33) Misses $(0.24) Estimate, Sales $5.561M Miss $5.565M Estimate

Benzinga Earnings
·
Jun 17

BRIEF-Sonoma Pharmaceuticals Q4 Net Income USD -600 Thousand

Reuters
·
Jun 17

Sonoma Pharmaceuticals Q4 Ebitda USD -200 Thousand

THOMSON REUTERS
·
Jun 17

Sonoma Pharmaceuticals FY26 net loss narrows to $3.18 million; revenue rises 37% to $19.53 million

Reuters
·
Jun 17

Top News Today: Stocks Gain With SpaceX Up 19% on Debut

Dow Jones
·
Jun 13

Sonoma Pharmaceuticals announces special shareholder meeting

Reuters
·
May 06

Sonoma Pharma prices USD 4 million follow-on stock offering at USD 1.35 per share

Reuters
·
May 01